Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Treatment Resistent Cancers

Treatment Resistent Cancers

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Cancer Therapies

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Use of traditional, complementary and integrative medicine in Berlin: baseline results from a substudy of the German National Cohort (NAKO).

BMJ public health·2026

Same author

Digital Twins as catalysts for Whole Person Health Mind Body Medicine in Integrative Oncology.

Frontiers in oncology·2026

Same author

Assessment of patient preferences in digital health trials: procedure development and implementation in a preference-based trial.

BMJ open·2026

Same author

Complementary therapies for multiple sclerosis: Scoping review with evidence gap map.

Multiple sclerosis and related disorders·2026

Same author

Acupuncture for chemotherapy-induced dysgeusia (AcuDysg): a randomized controlled trial.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026

Same author

Enhancing trial recruitment through a social media influencer campaign in the MeMaF study: a mixed methods approach.

Journal of clinical epidemiology·2026

Same journal

RETRACTION: Isolation of Antidiabetic Principle from Fruit Rinds of <i>Punica granatum</i>.

Evidence-based complementary and alternative medicine : eCAM·2026

Same journal

RETRACTION: Molecular Mechanism of Traditional Chinese Ointment of Xuzhou Qufu Shengji in Infected Wounds.

Evidence-based complementary and alternative medicine : eCAM·2026

Same journal

RETRACTION: Involvement of Endoplasmic Reticulum Stress in Capsaicin-Induced Apoptosis of Human Pancreatic Cancer Cells.

Evidence-based complementary and alternative medicine : eCAM·2026

Same journal

RETRACTION: Thujone-Rich Fraction of <i>Thuja occidentalis</i> Demonstrates Major Anti-Cancer Potentials: Evidences from In Vitro Studies on A375 Cells.

Evidence-based complementary and alternative medicine : eCAM·2026

Same journal

RETRACTION: Application of <i>Antrodia camphorata</i> Promotes Rat's Wound Healing <i>In Vivo</i> and Facilitates Fibroblast Cell Proliferation <i>In Vitro</i>.

Evidence-based complementary and alternative medicine : eCAM·2026

Same journal

RETRACTION: Catechins and Sialic Acid Attenuate <i>Helicobacter pylori</i>-Triggered Epithelial Caspase-1 Activity and Eradicate <i>Helicobacter pylori</i> Infection.

Evidence-based complementary and alternative medicine : eCAM·2026

See all related articles

Search research articles

Related Experiment Video

Updated: May 3, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Integrative oncology

Gustav Dobos¹, Holger Cramer¹, Shrikant Anant²

¹Department of Internal and Integrative Medicine, Kliniken Essen-Mitte, Faculty of Medicine, University of Duisburg-Essen, 45276 Essen, Germany.

Evidence-Based Complementary and Alternative Medicine : Ecam

|January 24, 2014

Summary

No abstract available in PubMed .

More Related Videos

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013

Related Experiment Videos

Last Updated: May 3, 2026

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Author Spotlight: Integrating Computational and Experimental Approaches in Precision Oncology

Published on: December 1, 2023

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization

Published on: December 2, 2013